General MedicationsINJECTIONGeneric
BRETYLIUM TOSYLATE
BRETYLIUM TOSYLATE
Standard Dose
100MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview BRETYLIUM TOSYLATE is listed in Drugs@FDA under application 071298 (ANDA).
Marketing status: Discontinued Active ingredient BRETYLIUM TOSYLATE Form and strength INJECTABLE;INJECTION - 100MG/ML Sponsor ABRAXIS PHARM Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview BRETYLIUM TOSYLATE is listed in Drugs@FDA under application 071298 (ANDA). Marketing status: Discontinued Active ingredient BRETYLIUM TOSYLATE Form and strength INJECTABLE;INJECTION - 100MG/ML Sponsor ABRAXIS PHARM Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.